Table S15 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer per Aditi S. Khatpe (15293176)

Altres autors:

Table S4 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer per Aditi S. Khatpe (15293176)

Altres autors:

Table S3 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer per Aditi S. Khatpe (15293176)

Altres autors:

Table S10 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer per Aditi S. Khatpe (15293176)

Altres autors:

Table S9 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer per Aditi S. Khatpe (15293176)

Altres autors:

Table S14 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer per Aditi S. Khatpe (15293176)

Altres autors:

Table S1 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer per Aditi S. Khatpe (15293176)

Altres autors:

Table S2 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer per Aditi S. Khatpe (15293176)

Altres autors:

Table S12 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer per Aditi S. Khatpe (15293176)

Altres autors:

Table S13 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer per Aditi S. Khatpe (15293176)

Altres autors:

Table S11 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer per Aditi S. Khatpe (15293176)

Altres autors:

Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma per Alyssa C. Flint (16676029)

Altres autors:

Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma per Alyssa C. Flint (16676029)

Altres autors: